ARTICLE | Financial News
Unity proposes $85M IPO
April 13, 2018 1:42 PM UTC
On April 5, Unity Biotechnology Inc. (Brisbane, Calif.) filed to raise up to $85 million in an IPO on NASDAQ underwritten by Goldman Sachs, Morgan Stanley, Citigroup and Mizuho.
Unity's lead candidates target senescent cells to treat age-related diseases (see BioCentury, Oct. 31, 2016)...